[…] New Model for Predicting Cervical Cancer Survival Washington, February 15, 2022A recently published article in “Experimental Biology and Medicine” (Volume 247, Issue 3, February, 2022), describes a new method for evaluating cervical cancer prognosis. The study, led by Dr. Zhong Lin in the Department of Obstetrics and Gynecology at Liuzhou Maternity and Child Health Care Hospital in Liuzhou (China), reports a six gene signature that predicts overall survival of cervical cancer patients […] weiterlesen …
[…] reports on the completed Phase I study of the drug candidate, Supernitro—paving the way for the next stage in the development of future treatments for acute pulmonary hypertension The last of 38 study participants were treated with Supernitro on 18 May, and the substance has shown good safety and tolerability. No unexpected side effects have been reported. At a higher dose and longer treatment, the expected side effects have been noted in line with the substance mechanism of […] weiterlesen …